What is indapamide used for? Indapamide is a diuretic, also called a water pill, that is commonly used to reduce fluid retention caused by congestive heart failure. Indapamide is also used to treat ...

Although many data indicate that the management of hypertension has improved over the last two decades, there is still a large proportion of hypertensive individuals who do not receive adequate ...

It's important to tell your doctor or pharmacist what medicines you are already taking, including those bought without a prescription and herbal medicines, before you start treatment with indapamide.

Hypertension can cause heart, brain, kidney and artery damage, increasing the incidence of cardiovascular disease and death. The purpose of antihypertensive treatment is not only lowering the blood ...

This leaflet answers some common questions about ODAPLIX SR. It does not contain all the available information about this medicine. Reading this leaflet does not take the place of talking to your ...

Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good tolerability ...

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill ...

* ANI Pharmaceuticals -launch of Indapamide tablets, 1.25mg and 2.5mg, used in treatment of hypertension & swelling associated with congestive heart failure Source text for Eikon: Further company ...

Clin Drug Invest. 2007;27(6):367-380. Fogari et al. [46] investigated the antihypertensive effects of four possible dose combinations of delapril 15 or 30mg and indapamide 1.25 or 2.5mg. They found ...

An innovative single pill combination of three medicines, including two doses that are lower than those currently available in single pill combinations, that can deliver the blood pressure-lowering ...

London, UK, Boston, MA, USA, 21 July 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an ...